Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based biotechnology company, Raven, has appointed Michael Kranda as chairman of the board. Mr. Kranda replaces Bill Young who remains on the Raven board as a director.
Subscribe to our email newsletter
Mr. Kranda led life sciences venture investments as managing director for Vulcan Capital through 2006 and continues to consult for Vulcan. He sits on the board of directors of several companies including BiPar Sciences and PTC Therapeutics.
George Schreiner, CEO of Raven, said: “We are delighted to have Michael’s continuing leadership as board chair, and I look forward to working with him to advance our goals.”